BioPharma Institute Launches 5 Top U.S. Pharmaceutical & Clinical Research Industry Regulatory Compliance Courses as Parent Company Celebrates 20th Anniversary

Share Article

The BioPharma Institute Announces 5 Exciting New Courses, Including Regulation 21 CFR Part 11 Training, to Coincide with the Milestone of its Parent Company's 20th Year in Business

BioPharma Institute

Providing Pharmaceutical & Clinical Professionals with High Quality Training, Literature, and Certification Programs

It's an honor to serve the on-going regulatory training requirements of small to mid-sized clinical research organizations, drug manufacturers, contractors, and professionals seeking to advance rewarding careers within these important sectors.

Today, BioPharma Institute, a leading training platform for highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 new courses to its prospectus. These include the eagerly-awaited Regulation 21 CFR Part 11 training - Compliance with Regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures (Part 11 of Title 21 of the U.S. Code of Federal Regulations for computer systems in FDA-regulated environments). The Institute’s other new courses include Introduction to Drug Safety and Pharmacovigilance, Risk Management Planning for Medicinal Products, How to Gain Approval to Market a Generic Drug in the U.S., and How to Gain Approval for Clinical Trials in the USA. These new courses join the extensive list of programs training on good manufacturing practices (GMP), good laboratory practices (GLP), and good clinical practices (GCP).

Providing many world-class training programs and courses, the BioPharma Institute is trusted by thousands of highly skilled biopharmaceutical industry professionals working in FORTUNE 500 and other corporations in the U.S., plus 10 other countries worldwide. Additionally, Continuing Professional Development (CPD) points for many of its courses are recognized by the distinguished Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom. "We're delighted with the addition of 5 courses to an already extensive list of 100+ regulatory and compliance programs," asserted Algis Rajeckas, Ph.D., Director of Marketing at the BioPharma Institute. “Given our history, our aim is to continue to exceed the expectations of biopharmaceutical and clinic research professionals."

With headquarters in Paramus, New Jersey, the BioPharma Institute, a division of GeneTree, Inc. (celebrating its 20th anniversary), was founded in 2003 to provide industry-leading training solutions for professionals that are convenient, efficient, and effective for training those working in the highly regulated pharmaceutical, biotechnology, clinical research, and healthcare industries. "There's a tremendous range of courses available concentrating on regulatory affairs, as well as performing good manufacturing, clinical, and laboratory practices for industry professionals," explained, Fardad Gharebaghi, Commercial Director, LeoPink (a BioPharma Institute Content Partner). "The BioPharma Institute stands out as a premier training portal for professionals and corporations.”

Content-rich online training programs, including automated tracking systems and managed training records, have become a hallmark of the BioPharma Institute’s advanced e-learning certification classes for companies and employees. Its goal is to constantly update and offer the finest regulatory and compliance training course options in a state-of-the-art e-learning environment. "It's an honor to serve the on-going regulatory training requirements of small to mid-sized clinical research organizations, drug manufacturers, contractors, and professionals seeking to advance rewarding careers within these important sectors," expressed, Terry Carmichael, Managing Director and Founder of GeneTree, Inc. "In the past 14 years since launching the BioPharma Institute, we provided training to customers in a total of 11 countries, across 3 continents. We look forward to the future growth of the BioPharma Institute and all of our online training participants.”

About BioPharma Institute:
Since 2003, BioPharma Institute, a division of GeneTree, Inc., established in 1997, has been a leading provider of excellence in regulatory training for thousands of professionals and corporations seeking to excel in their industries. From its base in Paramus, New Jersey, BioPharma Institute offers convenient, efficient, and effective training solutions for those working in the highly regulated pharmaceutical, clinical research, biotechnology, and healthcare industries. Trusted for over 14 years, BioPharma Institute has aggregated a comprehensive range of web-based courses, books, live and recorded seminars, and other powerful training tools. Discover the future of e-learning today by visiting biopharmainstitute.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Algis Rajeckas, Ph.D.
BioPharma Institute
+1 (201) 301-8370 Ext: 212
Email >

Terrence C Carmichael
@GeneticsNetwork
since: 06/2009
Follow >
BioPharma Institute
since: 08/2010
Like >
BioPharma Institute

Follow us on
Visit website